Yen-Jung Chiu

Yen-Jung Chiu

Auto-generated profile, based on publicly available information

Yen-Jung Chiu

Affiliation Department of Biomedical Engineering, Chang Gung University, Taoyuan, Taiwan

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 May 2024 in Heliyon
Verified
Journal Article
Open access
YCYen-Jung Chiu
Yen-Jung Chiu
A novel automated medication verification system (AMVS) aims to address the limitation of manual medication verification among healthcare professionals with a high workload, thereby reducing medication errors in hospitals. Specifically, the manual medication verification process is time-consuming and prone to errors, especially in healthcare settings with high workloads. The proposed system strategy is to streamline and automate this process, enhancing efficiency and reducing medication errors. The system employs deep learning models to swiftly and accurately classify multiple medications within a single image without requiring manual labeling during model construction. It comprises edge detection and classification to verify medication types. Unlike previous studies conducted in open spaces, our study takes place in a closed space to minimize the impact of optical changes on image capture. During the experimental process, the system individually identifies each drug within the image by edge detection method and utilizes a classification model to determine each drug type. Our research has successfully developed a fully automated drug recognition system, achieving an accuracy of over 95 % in identifying drug types and conducting segmentation analyses. Specifically, the system demonstrates an accuracy rate of approximately 96 % for drug sets containing fewer than ten types and 93 % for those with ten types. This verification system builds an image classification model quickly. It holds promising potential in assisting nursing staff during AMVS, thereby reducing the likelihood of medication errors and alleviating the burden on nursing staff.

27 June 2023 in Cancer Medicine
Verified
Journal Article
Open access
YCYen‐Jung Chiu
Yen‐Jung Chiu
CNChung‐En Ni
Chung‐En Ni
YHYen-Hua Huang
Yen-Hua Huang
Background: Many studies have utilized computational methods, including cell composition deconvolution (CCD), to correlate immune cell polarizations with the survival of cancer patients, including those with hepatocellular carcinoma (HCC). However, currently available cell deconvolution estimated (CDE) tools do not cover the wide range of immune cell changes that are known to influence tumor progression.Results: A new CCD tool, HCCImm, was designed to estimate the abundance of tumor cells and 16 immune cell types in the bulk gene expression profiles of HCC samples. HCCImm was validated using real datasets derived from human peripheral blood mononuclear cells (PBMCs) and HCC tissue samples, demonstrating that HCCImm outperforms other CCD tools. We used HCCImm to analyze the bulk RNA‐seq datasets of The Cancer Genome Atlas (TCGA)‐liver hepatocellular carcinoma (LIHC) samples. We found that the proportions of memory CD8+ T cells and Tregs were negatively associated with patient overall survival (OS). Furthermore, the proportion of naïve CD8+ T cells was positively associated with patient OS. In addition, the TCGA‐LIHC samples with a high tumor mutational burden had a significantly high abundance of nonmacrophage leukocytes.Conclusions: HCCImm was equipped with a new set of reference gene expression profiles that allowed for a more robust analysis of HCC patient expression data. The source code is provided at https://github.com/holiday01/HCCImm.

24 April 2025 in Biomedicines
Verified
Journal Article
Open access
PDF file
SCShao-Hsuan Chang
Shao-Hsuan Chang
LYLung-Kun Yeh
Lung-Kun Yeh
KHKuo Hsuan Hung
Kuo Hsuan Hung
YCYen-Jung Chiu
Yen-Jung Chiu
JHJason Chia-Hsun Hsieh
Jason Chia-Hsun Hsieh
CMChung-Pei Ma
Chung-Pei Ma
Background: Keratoconus (KTCN) is a multifactorial disease characterized by progressive corneal degeneration. Recent studies suggest that a gene expression analysis of corneas may uncover potential novel biomarkers involved in corneal matrix remodeling. However, identifying reliable combinations of biomarkers that are linked to disease risk or progression remains a significant challenge. Objective: This study employed multiple machine learning algorithms to analyze the transcriptomes of keratoconus patients, identifying feature gene combinations and their functional associations, with the aim of enhancing the understanding of keratoconus pathogenesis. Methods: We analyzed the GSE77938 (PRJNA312169) dataset for differential gene expression (DGE) and performed gene set enrichment analysis (GSEA) using Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways to identify enriched pathways in keratoconus (KTCN) versus controls. Machine learning algorithms were then used to analyze the gene sets, with SHapley Additive exPlanations (SHAP) applied to assess the contribution of key feature genes in the model’s predictions. Selected feature genes were further analyzed through Gene Ontology (GO) enrichment to explore their roles in biological processes and cellular functions. Results: Machine learning models, including XGBoost, Random Forest, Logistic Regression, and SVM, identified a set of important feature genes associated with keratoconus, with 15 notable genes appearing across multiple models, such as IL1R1, JUN, CYBB, CXCR4, KRT13, KRT14, S100A8, S100A9, and others. The under-expressed genes in KTCN were involved in the mechanical resistance of the epidermis (KRT14, KRT15) and in inflammation pathways (S100A8/A9, IL1R1, CYBB, JUN, and CXCR4), as compared to controls. The GO analysis highlighted that the S100A8/A9 complex and its associated genes were primarily involved in biological processes related to the cytoskeleton organization, inflammation, and immune response. Furthermore, we expanded our analysis by incorporating additional datasets from PRJNA636666 and PRJNA1184491, thereby offering a broader representation of gene features and increasing the generalizability of our results across diverse cohorts. Conclusions: The differing gene sets identified by XGBoost and SVM may reflect distinct but complementary aspects of keratoconus pathophysiology. Meanwhile, XGBoost captured key immune and chemotactic regulators (e.g., IL1R1, CXCR4), suggesting upstream inflammatory signaling pathways. SVM highlighted structural and epithelial differentiation markers (e.g., KRT14, S100A8/A9), possibly reflecting downstream tissue remodeling and stress responses. Our findings provide a novel research platform for the evaluation of keratoconus using machine learning-based approaches, offering valuable insights into its pathogenesis and potential therapeutic targets.

8 November 2024
Verified
Conference Paper
Open access
YCYen-Jung Chiu
Yen-Jung Chiu
CCChao-Chun Chuang
Chao-Chun Chuang
Kuo-Yuan HwaKuo-Yuan Hwa
Kuo-Yuan Hwa
Large Language Models (LLMs) have revolutionized natural language processing (NLP) with significant advancements in text generation. LLMs often struggle with complex domain-specific tasks, such as medical report analysis, despite their capabilities. This study focuses on enhancing LLM performance for medical applications, particularly in diagnosing and managing cardiogenic pulmonary edema (CPE). This research explores fine-tuning LLMs to develop a real-time CPE chatbot for Intensive Care Units (ICUs). The chatbot aims to provide diagnostic suggestions and explanations based on patient data. In the results, the LLaMa3-8B model performed better in predicting patients' CPE stage and keyword extraction. The accuracies achieved 72% and 86%.

9 November 2023
Verified
Conference Paper
Open access
YCYen-Jung Chiu
Yen-Jung Chiu
CCChao-Chun Chuang
Chao-Chun Chuang
STShih-Tsang Tang
Shih-Tsang Tang
Cardiogenic pulmonary edema encompasses a diversity of subtypes, each of which requires specific treatment strategies. Physicians must have the ability to rapidly identify edema subtypes in medical images to achieve timely intervention and mitigate lung impairment. This study compared six supervised classification models pre-trained and tested using the MIMIC-CXR dataset in the identification of cardiogenic pulmonary edema subtypes. Note that the same analytic methods were consistently applied across the six parameter sets. Fine-tuning the windowing to L: 2500 and W: 3000 resulted in five AUC values that surpassed 0.8, despite the fact that this did not result in peak accuracy across all test data categories. The predictive accuracy for vascular congestion reached 90%, while that of interstitial and alveolar edema reached 96%. This research holds significant potential for the early diagnosis and targeted treatment of cardiogenic pulmonary edema to enhance the standard of patient care.

9 January 2026 in PLOS ONE
Verified
Journal Article
Open access
PDF file
YCYen-Jung Chiu
Yen-Jung Chiu
Characterizing the tumor immune microenvironment from histopathological images offers opportunities for ex vivo immune profiling and prognostic assessment. However, the TCGA-LIHC dataset lacks direct immune cell composition data. Therefore, this study aims to introduce Liver Immune Microenvironment Prediction and Classification Attention Transformer (LIMPACAT), a deep learning framework that leverages whole-slide images (WSIs) to predict immune cell levels relevant to hepatocellular carcinoma (HCC) prognosis. Immune cell compositions were inferred using a deconvolution approach, with bulk RNA-seq profiles simulated from liver-specific single-cell RNA sequencing data and processed with multiple normalization methods. These inferred compositions served as supervision signals to train a multiple instance learning model with an attention transformer. LIMPACAT exhibited ~80% accuracy in classifying immune cell levels from HCC WSIs, showing strong concordance between model prediction and deconvolution-derived estimates. These findings suggest that WSIs can serve as a proxy for immune profiling, facilitating pathology-based tumor microenvironment assessment and supporting personalized therapeutic strategies.